Gsa Capital Partners LLP Champions Oncology, Inc. Transaction History
Gsa Capital Partners LLP
- $1.43 Billion
- Q2 2025
A detailed history of Gsa Capital Partners LLP transactions in Champions Oncology, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 10,415 shares of CSBR stock, worth $67,697. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,415Holding current value
$67,697% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CSBR
# of Institutions
34Shares Held
5.81MCall Options Held
35.4KPut Options Held
0-
Battery Management Corp. Boston, MA2.42MShares$15.7 Million3.14% of portfolio
-
Nea Management Company, LLC Timonium, MD1.71MShares$11.1 Million1.05% of portfolio
-
Tocqueville Asset Management L.P. New York, NY400KShares$2.6 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA327KShares$2.13 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny181KShares$1.18 Million0.0% of portfolio
About CHAMPIONS ONCOLOGY, INC.
- Ticker CSBR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,522,400
- Market Cap $87.9M
- Description
- Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...